129 related articles for article (PubMed ID: 5549410)
1. Catecholamine metabolism, depression and stress.
Maas JW; Dekirmenjian H; Fawcett J
Nature; 1971 Apr; 230(5292):330-1. PubMed ID: 5549410
[No Abstract] [Full Text] [Related]
2. Catecholamine metabolism, depressive illness, and drug response.
Maas JW; Fawcett JA; Dekirmenjian H
Arch Gen Psychiatry; 1972 Mar; 26(3):252-62. PubMed ID: 4551050
[No Abstract] [Full Text] [Related]
3. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate.
Greenspan K; Schildkraut JJ; Gordon EK; Baer L; Aronoff MS; Durell J
J Psychiatr Res; 1970 Feb; 7(3):171-83. PubMed ID: 5440858
[No Abstract] [Full Text] [Related]
4. Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline.
Schildkraut JJ; Draskoczy PR; Gershon ES; Reich P; Grab EL
J Psychiatr Res; 1972 Sep; 9(3):173-85. PubMed ID: 5083173
[No Abstract] [Full Text] [Related]
5. MHPG excretion by patients with affective disorders.
Maas JW; Dekirmenjian H; Fawcett JA
Int Pharmacopsychiatry; 1974; 9(1):14-26. PubMed ID: 4600126
[No Abstract] [Full Text] [Related]
6. Biochemical changes in psychotic depression. High norepinephrine levels in psychotic vs neurotic depression.
Bunney WE; Davis JM; Weil-Malherbe H; Smith ER
Arch Gen Psychiatry; 1967 Apr; 16(4):448-60. PubMed ID: 6022709
[No Abstract] [Full Text] [Related]
7. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.
Schildkraut JJ
Am J Psychiatry; 1973 Jun; 130(6):695-9. PubMed ID: 4701961
[No Abstract] [Full Text] [Related]
8. Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients.
Greenspan K; Schildkraut JJ; Gordon EK; Levy B; Durell J
Arch Gen Psychiatry; 1969 Dec; 21(6):710-6. PubMed ID: 4901154
[No Abstract] [Full Text] [Related]
9. The investigation of adrenergic metabolism with 7H3-norepinephrine in psychiatric disorders. II. Temporal changes in the distribution of urinary tritiated metabolites in affective disorders.
Rosenblatt S; Chanley JD; Leighton WP
J Psychiatr Res; 1969 May; 6(4):321-33. PubMed ID: 4307103
[No Abstract] [Full Text] [Related]
10. Adrenal function and alcoholism. II. Catecholamines.
Ogata M; Mendelson JH; Mello NK; Majchrowicz E
Psychosom Med; 1971; 33(2):159-80. PubMed ID: 5549660
[No Abstract] [Full Text] [Related]
11. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders.
Schatzberg AF; Samson JA; Bloomingdale KL; Orsulak PJ; Gerson B; Kizuka PP; Cole JO; Schildkraut JJ
Arch Gen Psychiatry; 1989 Mar; 46(3):260-8. PubMed ID: 2783211
[TBL] [Abstract][Full Text] [Related]
12. Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites.
Schildkraut JJ; Orsulak PJ; LaBrie RA; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA
Arch Gen Psychiatry; 1978 Dec; 35(12):1436-9. PubMed ID: 727879
[TBL] [Abstract][Full Text] [Related]
13. A psychopharmacological study of catecholamines in affective disorders.
Messiha FS; Savage C; Turek I; Hanlon TE
J Nerv Ment Dis; 1974 May; 158(5):338-47. PubMed ID: 4823934
[No Abstract] [Full Text] [Related]
14. A psychoendocrine study of pregnancy and puerperium.
Treadway CR; Kane FJ; Jarrahi-Zadeh A; Lipton MA
Am J Psychiatry; 1969 Apr; 125(10):1380-6. PubMed ID: 4388045
[No Abstract] [Full Text] [Related]
15. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
[TBL] [Abstract][Full Text] [Related]
16. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO
J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
[TBL] [Abstract][Full Text] [Related]
17. Excretion of catecholamine metabolites by children with familial dysautonomia.
Gitlow SE; Bertani LM; Wilk E; Li BL; Dziedzic S
Pediatrics; 1970 Oct; 46(4):513-22. PubMed ID: 5503687
[No Abstract] [Full Text] [Related]
18. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
Käser H; Türler K; Burri PH
Schweiz Med Wochenschr; 1971 Apr; 101(13):484-7. PubMed ID: 5558918
[No Abstract] [Full Text] [Related]
19. Psychoendocrine study of oral contraceptive agents.
Kane FJ; Lipton MA; Krall AR; Obrist PA
Am J Psychiatry; 1970 Oct; 127(4):443-50. PubMed ID: 4394090
[No Abstract] [Full Text] [Related]
20. Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities.
Deleon-Jones F; Maas JW; Dekirmenjian H; Sanchez J
Am J Psychiatry; 1975 Nov; 132(11):1141-8. PubMed ID: 1166890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
